Cardiac Magnetic Resonance: A Multi-Parametric Imaging to Guide Management in Chronic Ischemic Heart Failure


Chronic heart failure is a major public-health problem with a high prevalence, high mortality and complex treatment. A comprehensive analysis is needed to provide optimal therapy to these patients. Non-invasive imaging plays a central part by offering a complete approach in patients with ischemic heart disease (IHD). Cardiac magnetic resonance imaging (CMR) has emerged as an established advanced multi-parametric imaging modality for the functional and anatomical assessment of cardiovascular disease. This review describes the practical aspects of CMR imaging, and then discusses the role of CMR in the diagnosis and management of chronic IHD, its infarct related complications, such as secondary mitral regurgitation, left ventricular (LV) thrombus, and ventricular tachycardia (VT).


Download data is not yet available.


1. Mozaffarian D, et al. Heart disease and stroke statistics--2015 update: A report from the American Heart Association. Circulation. 2015;131(4):e29-322.
2. Bruder O, et al. European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson. 2013;15:9.
3. American College of Cardiology Foundation Task Force on Expert Consensus Documents, et al., ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol, 2010;55(23): 2614-62.
4. Raj V and Agrawal SK, Ischaemic heart disease assessment by cardiovascular magnetic resonance imaging. Postgrad Med J. 2010;86(1019):532-40.
5. Walsh TF and Hundley WG. Assessment of ventricular function with cardiovascular magnetic resonance. Magn Reson Imaging Clin N Am. 2007;15(4):487-504, v.
6. Sarwar A., et al. Cardiac magnetic resonance imaging for the evaluation of ventricular function. Semin Roentgenol. 2008;43(3):183-92.
7. Lamas GA, et al. Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction. Am J Cardiol. 1989;63(17):1167-73.
8. Lubbers DD, et al. The additional value of first pass myocardial perfusion imaging during peak dose of dobutamine stress cardiac MRI for the detection of myocardial ischemia. Int J Cardiovasc Imaging. 2008;24(1): 69-76.
9. Baer FM, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol. 1998; 31(5): 1040-8.
10. Schwitter J, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008;29(4): 480-9.
11. Nandalur KR, et al. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2007;50(14):1343-53.
12. Simonetti OP, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218(1):215-23.
13. Schellings MW, Pinto YM, Heymans S. Matricellular proteins in the heart: possible role during stress and remodeling. Cardiovasc Res. 2004.64(1): 24-31.
14. Rajappan K, et al. The role of cardiovascular magnetic resonance in heart failure. Eur J Heart Fail. 2000;2(3): 241-52.
15. Bello D, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation. 2003;108(16):1945-53.
16. Wagner A, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361(9355): 374-9.
17. Orn S, et al. Effect of left ventricular scar size, location, and transmurality on left ventricular remodeling with healed myocardial infarction. Am J Cardiol. 2007;99(8): 1109-14.
18. Romero J, et al. CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: A meta-analysis of prospective trials. JACC Cardiovasc Imaging. 2012;5(5):494-508.
19. Kim RJ, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343(20): 1445-53.
20. Shah DJ, et al. Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease. JAMA. 2013;309(9): 909-18.
21. Glaveckaite S, et al. Value of scar imaging and inotropic reserve combination for the prediction of segmental and global left ventricular functional recovery after revascularisation. J Cardiovasc Magn Reson. 2011;13: 35.
22. Iles L, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008;52(19):1574-80.
23. Weinsaft JW, et al. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol. 2008;52(2): 148-57.
24. Delewi R, Zijlstra F, Piek JJ. Left ventricular thrombus formation after acute myocardial infarction. Heart. 2012;98(23): 1743-9.
25. Rossi A, et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart. 2011; 97(20):1675-80.
26. Lancellotti P, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: Mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11(4): 307-32.
27. le Polain de Waroux JB, et al. Early hazards of mitral ring annuloplasty in patients with moderate to severe ischemic mitral regurgitation undergoing coronary revascularization: The importance of preoperative myocardial viability. J Heart Valve Dis. 2009;18(1):35-43.
28. Artis NJ, et al. Percutaneous closure of postinfarction ventricular septal defect: Cardiac magnetic resonance-guided case selection and postprocedure evaluation. Can J Cardiol. 2011;27(6): 869, e3-5.
29. Jensen CJ, et al. Right ventricular involvement in acute left ventricular myocardial infarction: Prognostic implications of MRI findings. AJR Am J Roentgenol. 2010;194(3):592-8.
30. Goldberger JJ, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation. 2008;118(14):1497-518.
31. Grupo de Estudo em Ressonancia e Tomografia Cardiovascular do Departamento de Cardiologia Clinica da Sociedade Brasileira de, C, et al. [Cardiovascular magnetic resonance and computed tomography imaging guidelines of the Brazilian Society of Cardiology]. Arq Bras Cardiol, 2006;87(3):e60-100.
Views & Downloads
Abstract views: 157   
PDF downloads: 27   
How to Cite
Cardiac Magnetic Resonance: A Multi-Parametric Imaging to Guide Management in Chronic Ischemic Heart Failure. (2017). Indonesian Journal of Cardiology, 38(1), 49-58.
Forum Pencitraan